Michele Andreucci

ORCID: 0000-0002-7974-3792
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Acute Kidney Injury Research
  • Dialysis and Renal Disease Management
  • Chronic Kidney Disease and Diabetes
  • Parathyroid Disorders and Treatments
  • Blood Pressure and Hypertension Studies
  • Diagnosis and Treatment of Venous Diseases
  • Diabetes Treatment and Management
  • Erythropoietin and Anemia Treatment
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Venous Thromboembolism Diagnosis and Management
  • Renal and Vascular Pathologies
  • Protease and Inhibitor Mechanisms
  • Central Venous Catheters and Hemodialysis
  • Muscle and Compartmental Disorders
  • Peripheral Artery Disease Management
  • Hormonal Regulation and Hypertension
  • Trauma, Hemostasis, Coagulopathy, Resuscitation
  • Cardiac, Anesthesia and Surgical Outcomes
  • Renal Diseases and Glomerulopathies
  • Iron Metabolism and Disorders
  • Ion Transport and Channel Regulation
  • Aortic aneurysm repair treatments
  • Cardiovascular Health and Disease Prevention
  • Liver Disease Diagnosis and Treatment
  • Heart Failure Treatment and Management

Magna Graecia University
2016-2025

Dulbecco Telethon Institute
2024

University of Ioannina
2024

Multidisciplinary Digital Publishing Institute (Switzerland)
2020

Department of Medical Sciences
2016-2017

Azienda Ospedaliero Universitario Mater Domini
2016

University of Palermo
2015

National Research Council
2015

Jeonbuk National University
2013

Universitätsklinikum Würzburg
2013

Significance Statement In this randomized crossover clinical trial in patients with CKD and without type 2 diabetes, we assessed the albuminuria-lowering effect of sodium glucose co-transporter (SGLT2) inhibitor dapagliflozin mineralocorticoid receptor antagonist (MRA) eplerenone individually combination. We demonstrated that effects alone are additive when they used combination, resulting a clinically relevant albuminuria reduction 53% after 4 weeks dapagliflozin-eplerenone treatment. The...

10.1681/asn.2022020207 article EN Journal of the American Society of Nephrology 2022-05-11

β-Catenin is a transcriptional activator that regulates embryonic development as part of the Wnt pathway and also plays role in tumorigenesis. The mechanisms leading to Wnt-induced stabilization β-catenin, which results its translocation nucleus activation transcription, have been an area intense interest. However, it not clear whether stimuli other than Wnts can lead important β-catenin and, if so, what factors mediate biologic processes might be regulated. Herein we report stabilized...

10.1073/pnas.0835895100 article EN Proceedings of the National Academy of Sciences 2003-03-31

Iron deficiency is a common cause of anaemia in non-dialysis chronic kidney disease (ND-CKD). Controversies exist about the optimal route administration for iron therapy. Liposomal iron, new generation oral with high gastrointestinal absorption and bioavailability low incidence side effects, seems to be promising strategy replacement. Therefore, we conducted study determine whether liposomal compared intravenous (IV) improves ND-CKD patients. In this randomized, open-label trial, 99 patients...

10.1093/ndt/gfu357 article EN Nephrology Dialysis Transplantation 2014-11-13

We tested for the presence of coronary calcifications in patients with chronic renal disease not on dialysis and studied its progression 181 consecutive non-dialyzed who were followed a median 745 days. Coronary (calcium score) tallied Agatston units by computed tomography, stratified into two groups their baseline calcium score (100 U or less over 100 U). Survival was measured progression. Cardiac death myocardial infarction occurred 29 significantly more frequent those scores (hazard ratio...

10.1038/ki.2011.69 article EN cc-by-nc-nd Kidney International 2011-03-30

Glycogen synthase kinase (GSK) 3beta is a negative regulator of stress-induced cardiomyocyte hypertrophy. It not clear, however, if GSK-3beta plays any role in regulating normal cardiac growth and function. Herein we report that transgenic mouse expressing wild type the heart has dramatic impairment post-natal as well markedly abnormal contractile The most striking phenotype, grossly impaired diastolic relaxation, which leads to increased filling pressures left ventricle massive atrial...

10.1074/jbc.m401413200 article EN cc-by Journal of Biological Chemistry 2004-05-01

Rational: Our aim was to investigate the quality of life (QoL) in 103 patients undergoing chronic hemodialysis (HD) an integrated assessment clinical, personological, and adaptation parameters, also a non-urban context.Objectives: We collected data from all HD attending four units. Clinical status assessed by Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines Age-adjusted Charlson Comorbidity Index (ACCI). Patients completed following questionnaires: Life Short Form (KDQOL-SF),...

10.1080/0886022x.2016.1244077 article EN cc-by Renal Failure 2016-10-25
Coming Soon ...